[ChinaNet Online Holdings, Inc. Reports First Quarter 2010 Financial Results Beijing, China, May 17, 2010 § First quarter 2010 adjusted net income § Company launches new growth initiatives § Company reaffirmed 2010 revenue guidance of $45.0 million and adjusted net income guidance of $14.1 million, representing 19.0% and 67.9% growth over 2009 revenue and adjusted net income, respectively § Management]
[ChinaNet Online Holdings, Inc. Reports First Quarter 2010 Financial Results Beijing, China, May 17, 2010 § First quarter 2010 adjusted net income § Company launches new growth initiatives § Company reaffirmed 2010 revenue guidance of $45.0 million and adjusted net income guidance of $14.1 million, representing 19.0% and 67.9% growth over 2009 revenue and adjusted net income, respectively § Management]
[ChinaNet Onlines, Reports First Quarter 2010 Financial Results Beijing, China, May 17, 2010 First quarter 2010justed netomempany launches new growth initiativesmpany reaffirmed 2010 revenue guidance of $45.0 million andjusted netome guidance of $14.1 million, representing 19.0% and 67.9% growth over 2009 revenue andjusted netome, respectively]
[ChinaNet Onlines, Reports First Quarter 2010 Financial Results Beijing, China, May 17, 2010 First quarter 2010justed netomempany launches new growth initiativesmpany reaffirmed 2010 revenue guidance of $45.0 million andjusted netome guidance of $14.1 million, representing 19.0% and 67.9% growth over 2009 revenue andjusted netome, respectively]
[NEWS RELEASE Skystar Bio-Pharmaceutical Reports 27% Growth in Revenue From Continuing Operations in First Quarter Fiscal Year 2010 Gross Margin of 53%; $0.15 Diluted Earnings Per Share; Fiscal 2010 Top Line Guidance Increased to $45.5 Million to $47.5 Million XI’AN, CHINA – May 18, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), First Quarter 2009 Highligh ts]
[NEWS RELEASE Skystar Bio-Pharmaceutical Reports 27% Growth in Revenue From Continuing Operations in First Quarter Fiscal Year 2010 Gross Margin of 53%; $0.15 Diluted Earnings Per Share; Fiscal 2010 Top Line Guidance Increased to $45.5 Million to $47.5 Million XI’AN, CHINA – May 18, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), First Quarter 2009 Highligh ts]
[Transcript of Earnings Call for Results from the First Quarter of 2010 May 12, 2010 This transcript has been edited for clarity. Operator: Good day, ladies and gentlemen. Welcome to the China XD Plastics’ 1Q10 earnings conference call. My name is Nicole and I will be your operator for today. At this time, all participants are in a listen-only mode.] [FORM 8-K CURRENT REPORT Date of Report: May 12, 2010 CHINA XD PLASTICS COMPANY LIMITED Nevada 333-134073 04-3836208 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) No. 9 Qinling Road, Yingbin Road Centralized Industrial Park Harbin Development Zone, Heilongjiang, China 150078 (Zip Code) 86-451-84346600 o o o o Item 2.02. Results of Operations and Financial]
[Transcript of Earnings Call for Results from the First Quarter of 2010 May 12, 2010 This transcript has been edited for clarity. Operator: Good day, ladies and gentlemen. Welcome to the China XD Plastics’ 1Q10 earnings conference call. My name is Nicole and I will be your operator for today. At this time, all participants are in a listen-only mode.] [FORM 8-K CURRENT REPORT Date of Report: May 12, 2010 CHINA XD PLASTICS COMPANY LIMITED Nevada 333-134073 04-3836208 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) No. 9 Qinling Road, Yingbin Road Centralized Industrial Park Harbin Development Zone, Heilongjiang, China 150078 (Zip Code) 86-451-84346600 o o o o Item 2.02. Results of Operations and Financial]
